Evidence map›Paper›PMID 23665031›Full record

ArticleFEBS letters2013

Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.

Guojin Wu, Ji-Bin Peng

Open access · hybridAbstract read
In one paragraph

Article in FEBS letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
  3. Article
  4. Review
  5. UBR5 is a novel regulator of WNK1 stability.American journal of physiology. Cell physiology · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. The roles of KLHL family members in human cancers.American journal of cancer research · 2022
    Review
  10. Review
  11. High glucose-induced effects on NaAmerican journal of physiology. Cell physiology · 2021
    Article
  12. Article
  13. The WNK signaling pathway and salt-sensitive hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.Journal of the American Society of Nephrology : JASN · 2018
    Article
  20. Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.American journal of physiology. Renal physiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Guojin WuNephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0006, USA.
Ji-Bin Peng
Pediatric Nephrology of Alabama · US

Funding

Regulation of WNK4, a protein kinase mutated in a hereditary form of hypertensionR01DK072154 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PENG, JI-BIN · 2007 to 2017
$2.2M
NIDDK NIH HHS R01 DK072154NIDDK NIH HHS R01DK072154
6 · The paper itself

Abstract

Mutations in with-no-lysine (K) kinase 4 (WNK4) and a ubiquitin E3 ligase complex component kelch-like 3 (KLHL3) both cause pseudohypoaldosteronism II (PHAII), a hereditary form of hypertension. We determined whether WNK4 or its effector is regulated by KLHL3 in Xenopus oocytes. KLHL3 inhibited the positive effect of WNK4 on Na(+)-Cl(-) cotransporter (NCC) by decreasing WNK4 protein abundance without decreasing that of NCC and the downstream kinase OSR1 directly. Ubiquitination and degradation of WNK4 were induced by KLHL3. The effect of KLHL3 on WNK4 degradation was blocked by a dominant negative form of cullin 3. All five PHAII mutations of KLHL3 tested disrupted the regulation on WNK4. We conclude that KLHL3 is a substrate adaptor for WNK4 in a ubiquitin E3 ligase complex.

Indexed as

MutationProteolysisAdaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCullin ProteinsHumansMiceMicrofilament ProteinsProtein Serine-Threonine KinasesProtein StabilityPseudohypoaldosteronismReceptors, DrugSolute Carrier Family 12, Member 3SymportersUbiquitinationAdaptor Proteins, Signal TransducingCarrier ProteinsCUL3 protein, humanCullin ProteinsKLHL3 protein, humanMicrofilament ProteinsProtein Serine-Threonine KinasesReceptors, DrugSlc12a3 protein, mouseSolute Carrier Family 12, Member 3SymportersUbiquitin-Protein LigasesWNK4 protein, human

Identifiers

PMID23665031
PMCPMC3697765
OpenAlexW2015931350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.